DCM Consortium PIs Rate Traditional Genetic Care Models More Acceptable Than Physician-Led Models
Which way to test for heart disease feels right to doctors?
A cross-sectional needs assessment of 24 Principal Investigators in the DCM Consortium found traditional synchronous and asynchronous geneti…
Doctors prefer traditional in-person visits over remote options when checking for genetic heart risks, though care for this condition varies…
Observational EHR study suggests GLP-1 RA may have lower risk than SGLT2i for HF outcomes
Observational study links GLP-1 RA to lower risk than SGLT2i in heart failure patients
An observational study using real-world EHR data from Stony Brook University Hospital compared GLP-1 RAs to SGLT2 inhibitors in patients wit…
In heart failure patients, GLP-1 receptor agonists showed a lower risk of death or hospitalization compared to SGLT2 inhibitors over one yea…
Higher hospital cardiac capability tiers associated with lower mortality in cardiogenic shock hospitalizations
Does where you get emergency heart care matter for your survival in cardiogenic shock?
A national observational review of 1,177,180 cardiogenic shock hospitalizations found that higher hospital cardiac capability tiers were ind…
Patients with life-threatening heart failure had lower death rates at advanced hospitals, even when transferred from other facilities.
Health behaviors explain 40% of occupational class CVD inequality in Helsinki municipal employees
Unhealthy habits explained part of heart disease risk linked to lower job status in this Finnish study
A longitudinal study of Helsinki municipal employees aged 40-60 found health behaviors explained approximately 40% of the excess CVD risk in…
Insufficient physical activity is the strongest predictor of heart disease risk, yet unhealthy diets drive more risk among higher-status wor…
LEGEND rule-out strategy reduces length of stay and testing in suspected ACS patients across four Australian emergency departments
A new strategy safely shortens hospital stays for suspected heart attacks
This stepped-wedge cluster randomized controlled trial evaluated the LEGEND rule-out strategy, which integrates high-sensitivity cardiac tro…
A new hospital strategy safely shortens stays for suspected heart attacks by 3.6 hours while getting more patients home within 4 hours.
Catheter ablation reduces cardiovascular risk in atrial fibrillation with normal left atrial diameter but not in enlarged atria
Atrial fibrillation ablation benefits vary by heart size in large trial
This randomized controlled trial evaluated 1130 patients with atrial fibrillation who underwent baseline echocardiographic measurement of le…
Patients with normal-sized hearts gain the most life-saving benefit from atrial fibrillation ablation compared to those with enlarged hearts…
Intensive medical treatment failed to reduce major adverse cardiovascular events in women with suspected ANOCA/INOCA over 2.5 years.
Intensive heart medication did not reduce major events in women with suspected ANOCA
This randomized controlled trial enrolled 2,476 women with suspected ANOCA/INOCA across 71 US sites. Over a 2.5-year follow-up, intensive me…
Intensive heart medication did not reduce major events in women with suspected ANOCA, finding that aggressive treatment offered no benefit o…
LGE-CMR positivity associates with higher sudden cardiac death risk in ICD and CRT candidates
Heart Scans Show Higher Sudden Death Risk in Some Patients Before Device Implantation
This systematic review and meta-analysis evaluated 2,494 patients selected for implantable cardioverter defibrillator (ICD) or cardiac resyn…
Heart scans showing scar tissue reveal a 72% higher risk of sudden death for patients needing life-saving heart devices.
Network meta-analysis of pharmacotherapies shows GLP-1 RAs and SGLT2is reduce composite cardiovascular death and hospitalization in HFpEF.
New drugs may lower heart failure risk and improve walking distance for patients with preserved ejection fraction
This network meta-analysis evaluated 48,235 patients with heart failure with preserved ejection fraction (HFpEF) treated with various pharma…
New heart drugs lower death risk and hospital visits for patients with preserved ejection fraction while improving walking distance.
Network meta-analysis of 14 RCTs shows upfront plaque modification increases minimum stent area but does not reduce MACE or TLR in calcified coronary lesions.
New study finds risky plaque removal methods do not lower heart attack risk
This network meta-analysis of 14 randomized controlled trials involving 3,671 patients evaluated various plaque-modification strategies vers…
Special tools to break up hard heart plaque open arteries wider but do not lower the risk of heart attack or death compared to standard ball…
Elevated soluble ST2 predicts atrial fibrillation development and recurrence after catheter ablation in 14,582 participants.
High sST2 levels linked to higher risk of atrial fibrillation and recurrence
This systematic review and meta-analysis of 19 studies involving 14,582 participants examined the association between soluble ST2 (sST2) lev…
High blood levels of a protein called sST2 signal a greater risk of developing atrial fibrillation and its return after heart treatment.
Combined LAPVI improved sinus rhythm maintenance versus PVI alone in persistent AF patients.
Combined Ablation Technique Improves Rhythm Control in Persistent Atrial Fibrillation Patients
This randomized controlled trial evaluated 228 patients with persistent atrial fibrillation comparing combined Left Atrial Posterior Wall Li…
Adding a specific linear ablation to standard heart surgery helps 75% of persistent atrial fibrillation patients maintain normal rhythm comp…